Low-dose regimen of interleukin-2 for metastatic renal carcinoma.
Sleijfer
D T
DT
Janssen
R A
RA
Willemse
P H
PH
Martens
A
A
de Leij
L
L
de Vries
E G
EG
Mulder
N H
NH
D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D004334:Drug Administration Schedule; D005260:Female; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000556:secondary; D007958:Leukocyte Count / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D008875:Middle Aged
D006680:HLA Antigens; D007376:Interleukin-2